Earnings ·
High Tide Inc. announced preliminary guidance for its third fiscal quarter ended July 31, 2026, projecting record…
HITIHigh Tide Inc.
High Tide Inc. announced preliminary guidance for its third fiscal quarter ended July 31, 2026, projecting record financial performance with revenue between C$195.0 million and C$200.0 million, gross profit of $51.0–$53.5 million, and Adjusted EBITDA of $15.2–$16.5 million. These estimates exceed the highest analyst consensus figures for all three metrics and represent year-over-year growth of at least 30% in revenue, 27% in gross profit, and 43% in Adjusted EBITDA. The company also reported that its German subsidiary, Remexian Pharma GmbH, distributed over 10 tonnes of medical cannabis flower during the quarter, marking a 60% year-over-year increase. High Tide operates in the cannabis industry, providing retail services through Canna Cabana and wholesale distribution of medical cannabis.